Search

You searched for "LASIK"

966 results found

Carleton Optical Equipment Ltd is recruiting for its expanding Glaucoma team

17 January 2023 | Recruitment & Personnel
Business Manager - We are looking for an ambitious and capable business manager responsible for the South of England.

Andy Biart joins Carleton Optical as Surgical Business Manager, South

28 March 2023 | Recruitment & Personnel
Carleton are pleased to welcome Andy Biart to their surgical team.

Eyes on Rwanda: Lessons from an international ophthalmology experience

2 October 2025 | | EYE - Cataract, EYE - Glaucoma
On the 26 February 2025, I travelled to Rwanda on the invitation of a former Belfast trainee, Michael Mikhail. Michael is now one of only two vitreoretinal (VR) surgeons in Rwanda, a country with a population of 14 million. Born...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Best way to detect glaucoma progression: by reflecting on the past 25 years

1 June 2018 | | EYE - Glaucoma
Glaucoma – a condition of optic neuropathy leading to progressive visual field loss often associated with raised intraocular pressure. It is fair to say that our definition for this condition has remained unchanged over the last 25 years and the...

The adverse effects of COVID-19 on undergraduate ophthalmology education: An opportunity to reform ophthalmology training

11 January 2021 | | EYE - General
The steady erosion of undergraduate ophthalmology teaching, which has been acutely exacerbated by the COVID-19 crisis, has led to a lack of basic ophthalmology examining skills and knowledge amongst clinicians of other specialities. Concurrently, there has been a rise in...

Valuable resources for FRCOphth Part 1 exam preparation

24 November 2021 | | EYE - General
The FRCOphth Part 1 exam is a difficult exam with an average pass rate of 46% in the last year. It is a requirement before entry into the third year of ophthalmology specialty training (OST). Passing this exam during foundation...

Diabetes and diabetic retinopathy: Changes in understanding of the disease over the last 25 years and how the UK is helping low-income countries tackle the challenges

1 June 2018 | | EYE - Vitreo-Retinal, EYE - General
Diabetes – a historical perspective Diabetes mellitus (DM) is a chronic disease caused by inherited and / or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. Such a deficiency results in...

What's trending Apr/May 2021

6 April 2021 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #COVID-19prevention #spectacles Ocular transmission of COVID-19 was discussed from the very beginning of the pandemic [1-3]. Indeed, it was an Ophthalmologist,...

“Steel True, Blade Straight”

1 October 2019 | | EYE - General
Steven Kerr of the Royal College of Surgeons of Edinburgh explores the medical career of Arthur Conan Doyle, his relationship with his mentor Joseph Bell and his fascination with ophthalmology. Arthur Ignatius Conan Doyle was born in Edinburgh on the...

The embryology of the eye

1 December 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Orbit, EYE - Oncology, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Nobody claims to like embryology. At least nobody I know. It has been a neglected part of the curriculum since time immemorial and a vicious cycle occurs in which those with an incomplete understanding fail to appreciate the inherent beauty...

Johnson & Johnson announces lead vaccine candidate for COVID-19

30 March 2020
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate and the rapid scaling of its manufacturing capacity with the goal of providing global supply of more than one billion doses.